Science
How the FDA allows companies to add secret ingredients to our food

It’s a U.S. Food and Drug Administration rule that most Americans know little about, yet gives corporations the license to add potentially harmful ingredients to foods without regulatory oversight or public notice.
For decades, the FDA’s “generally recognized as safe,” or GRAS, designation has allowed food makers to decide for themselves whether certain novel ingredients are safe or not — even without providing evidence to agency scientists.
Consumer advocates claim the system has allowed companies to add harmful chemicals, including suspected carcinogens, to such products as cereals, baked goods, ice cream, potato chips and chewing gum.
Now, President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Service promises to elevate the issue. Although Kennedy’s penchant for amplifying medical conspiracies and his anti-vaccination activism have alarmed many public health experts, his vow to crack down on chemical additives in food has resonated with consumer health advocates.
The problem, critics say, is that a GRAS determination is supposed to follow a scientific assessment, ideally one conducted by independent experts.
Under the law, however, it is entirely optional for companies to share their assessments with FDA reviewers. That means the FDA and American consumers are in the dark about hundreds of compounds in processed foods.
“FDA cannot ensure the safety of our food supply if it does not know what is in our food,” said Thomas Galligan, principal scientist for food additives and supplements at the Center for Science in the Public Interest.
When the agency does learn about a new compound, it evaluates the company’s safety report to see whether it agrees. If FDA scientists see problems and request additional information, the company doesn’t have to provide it. It can simply withdraw its GRAS notice and use the ingredient anyway.
Natalie Mihalek, a former prosecutor and current state legislator in Pennsylvania, said she doesn’t understand why the FDA treats food additives like criminal defendants — “innocent until proven guilty, safe until proven otherwise.”
“Right now we’re relying on the companies that are going to profit off selling these substances to do the research for us,” said Mihalek, a Republican who has introduced a bill to ban six food dyes in her state. “It just blows my mind.”
FDA officials acknowledge the limits of the GRAS system but say they don’t have the authority to change it.
“Congress sets GRAS as part of the law,” said Kristi Muldoon Jacobs, director of the FDA’s Office of Food Additive Safety. “It is our responsibility to administer the law. We do not in fact have the authority to make the laws.”
Concern about the safety and purity of food prompted Congress to pass the Food and Drugs Act in 1906, just months after Upton Sinclair brought the meatpacking industry’s unsanitary practices to light in his book “The Jungle.” The new law forbade the manufacture and sale of foods that were “adulterated or misbranded or poisonous.”
The FDA’s regulatory powers expanded in 1938 with the passage of the Food, Drug and Cosmetic Act, and a 1958 amendment divided food ingredients into two categories: additives that must be assessed for safety, and substances that could go straight into foods because they are “generally recognized as safe.”
Unfortunately, the legal distinction between the two kinds of ingredients is “very vague,” said Jennifer Pomeranz, a public health lawyer at New York University’s School of Global Public Health.
The types of ingredients that were considered GRAS in 1958 included items that were already in wide use, such as salt, vanilla extract, baking powder and vinegar.
The FDA established a list of GRAS substances and added new items if they passed a safety review. Individuals from outside the agency also could ask to have a particular substance studied for inclusion on the official GRAS list.
But the process was time-consuming, and petitions from industry could take six years or more to evaluate. As part of the Clinton-era initiative to streamline government operations, the FDA embraced a newer, faster system designed to make it more enticing for companies to keep the agency in the loop about their GRAS decisions. Now the FDA pledges to respond to GRAS notices within 180 days.
The notification process is also low-risk for food companies.
If everything looks good, the FDA says it has “no questions” about the compound, effectively endorsing the GRAS assessment. This happens about 80% of the time, according to researchers Thomas Neltner and Maricel Maffini, who analyzed notices filed with the agency.
If things aren’t so clear, the agency may say it needs more information before it can weigh in. And if a company decides not to provide that information, it can back out of the process and the FDA will say it ended its evaluation at the filer’s request.
Such was the case with an ingredient in Sleepy Chocolate.
Not just another gourmet candy bar, the dark chocolate with lavender and blueberry flavors is infused with the hormone melatonin, the amino acid L-tryptophan, a blend of soothing botanicals and something called PharmaGABA, an artificial version of a neurotransmitter that calms the brain.
PharmaGABA is made by Pharma Foods International Co. of Kyoto, Japan. The company touts its product as having “US-FDA’s self-affirmed GRAS approval” even though the FDA twice raised serious concerns about its safety and has never indicated to the public that its misgivings were addressed.
Nothing about this violates the law.
Neltner, a chemical engineer and attorney, and Maffini, a biochemist and consultant, dug into the FDA’s files on PharmaGABA to see why regulators were concerned about it.
In its initial notice filed in 2008, Pharma Foods said it hired a Canadian consulting firm to determine whether PharmaGABA should qualify for GRAS status when used in candy, chewing gum, beverages and other products.
The consulting firm produced a report about the product and tapped three university professors with expertise in pharmacology, toxicology and food science to weigh in. The trio’s determination that the product was “safe and suitable and would be GRAS” was unanimous, according to the filing.
Yet after reviewing all 155 pages of the PharmaGABA notice, FDA scientists raised concerns about the product’s purity, its risk for causing low blood pressure and electrolyte imbalances, and the lack of data on how PharmaGABA is metabolized, among other problems.
Pharma Foods withdrew its notice, and the FDA ended its evaluation.
The company tried again in 2015 with a GRAS notice for using PharmaGABA in yogurts and cheese, cereals and snack bars, candy and gum, and an array of beverages including sports drinks and flavored milks. The same consulting firm assembled a scientific panel that said consuming PharmaGABA in expected quantities was “reasonably expected to be safe.”
As before, FDA reviewers had concerns. They said the new filing didn’t back the company’s claims that the product would be absorbed into the bloodstream at low levels and that it wouldn’t cross the blood-brain barrier. The reviewers were particularly concerned with the compound’s potential to harm pregnant women and children, as well as its effect on the pituitary gland.
Pharma Foods withdrew its notice so it could “conduct further studies,” and the FDA ceased its second evaluation of the product.
Maffini said it wasn’t unusual for agency scientists to find fault with GRAS decisions that passed muster with hired consultants. Giving their clients favorable reviews increases their chances of being hired again, she said.
Nine years later, Pharma Foods has yet to share additional results with the FDA. But PharmaGABA legally remains in Sleepy Chocolate based on Pharma Foods’ determination that the compound should be generally recognized as safe.
Pharma Foods International and Functional Chocolate Co., which makes Sleepy Chocolate, did not respond to requests to discuss PharmaGABA’s safety.
Maffini said she was frustrated that the FDA scientists who examined PharmaGABA couldn’t post a memo to warn the public about their concerns. (She and Neltner obtained the GRAS documents by filing a Freedom of Information Act request.)
“They ask questions,” Maffini said of the agency scientists, “but then there’s really nothing they can do.”
For every ingredient like PharmaGABA that is disclosed to the FDA, another probably makes its way to the market without any regulatory review.
By definition, there’s no way to know for sure how many new additives are granted GRAS status in secret. To make an estimate, researchers scoured websites and trade journals to find every corporate announcement of a new GRAS product during an eight-week period. Ten of those products weren’t on the FDA’s GRAS notice list.
If those eight weeks were typical, at least 65 new substances are being introduced into the food supply every year without any vetting by the agency. That’s on a par with the 60 to 70 GRAS notices that Muldoon Jacobs said the FDA evaluates each year.
The situation is something of a catch-22, Pomeranz said: Since GRAS products are presumed to be safe, they aren’t subject to regulatory review. But since they’re not regulated, how can the public be assured that they’re safe?
And that’s only part of the problem, she said. When companies use novel ingredients, they can list them on food labels using generic terms like “flavors” or “colors.” That makes it all but impossible for consumers to know that something new has been added to their food, she said.
This helps explain how an ingredient called tara flour was able to sicken hundreds of people who consumed French Lentil + Leek Crumbles, a meat replacement product sold by Daily Harvest in 2022. Customers suffered severe abdominal pain, fever, chills and acute liver failure, and more than 100 were hospitalized, according to the FDA. The company issued a voluntary recall and blamed a compound in tara flour for the illnesses.
Tara flour is a high-protein substance made from the seeds of an evergreen tree found in South America. There is no GRAS notice for the ingredient in the FDA’s database. Tests conducted after the outbreak found that an amino acid in the flour caused liver damage in mice.
In May, nearly two years after the recall, the FDA concluded that tara flour doesn’t meet the scientific standard to qualify for GRAS status. That makes it an unapproved food additive and is considered unsafe.
The agency added that it’s not aware of any products made in the U.S. that contain tara flour, nor has it identified any imported products that contain the ingredient.
The case shows why the FDA’s regulatory approach needs to change, said Jensen N. Jose, regulatory counsel for food chemical safety at the Center for Science in the Public Interest.
“Self-declaring that your chemical is safe should not be the law of the land,” Jose said. “I highly doubt that’s what Congress meant” when it created the GRAS designation in 1958, he said.
Bills introduced in the U.S. House and Senate would put an end to the practice of allowing companies to make GRAS determinations in secret. The legislation would require companies to share their scientific reviews and give the FDA and the public at least 90 days to review — and potentially challenge — them before they take effect, among other provisions.
But both bills have a ways to go in order to pass before the congressional term ends in January.
Jose has another idea for reducing the secrecy surrounding novel food ingredients: Require companies using self-declared GRAS ingredients to submit the safety data to the New York Department of Agriculture and Markets in Albany as a condition for selling their products in the Empire State.
Jose laid out the plan in a bill that is under consideration in the New York state Legislature. If it passes, state regulators would not be required to review the safety data, but at least it would become publicly available, he said.
“The goal is that you’d have a database so if something like tara flour happens, the FDA can look there and be able to respond more quickly,” Jose said.
Companies could avoid the notification requirement by keeping their products out of New York stores, but that would be a tip-off to watchdog groups like his, Jose said.
“If we find them selling everywhere except New York, we’ll know there might be something wrong with this chemical,” he said.
Jim Jones, the FDA’s deputy commissioner for human foods, has acknowledged the “growing public demand for the FDA to do more to ensure the safety of chemicals currently in the U.S. food supply.”
California and other states have sought to fill the void by regulating or banning select food additives within their borders. But “a strong national food-safety system is not built state-by-state,” Jones said. “The FDA must lead the way.”

Science
The Trump Administration Wants Seafloor Mining. What Does That Mean?

Life at the bottom of the Pacific Ocean is slow, dark and quiet. Strange creatures glitter and glow. Oxygen seeps mysteriously from lumpy, metallic rocks. There is little to disturb these deep-ocean denizens.
“There’s weird life down here,” said Bethany Orcutt, a geomicrobiologist at Bigelow Laboratory for Ocean Sciences.
Research in the deep sea is incredibly difficult given the extreme conditions, and rare given the price tag.
On Thursday, President Trump signed an executive order that aims to permit, for the first time, industrial mining of the seabed for minerals. Scientists have expressed deep reservations that mining could irreversibly harm these deep-sea ecosystems before their value and workings are fully understood.
What’s down there, anyway?
Seafloor mining could target three kinds of metal-rich deposits: nodules, crusts and mounds. But right now, it’s all about the nodules. Nodules are of particular value because they contain metals used in the making of electronics, sophisticated weaponry, electric-vehicle batteries and other technologies needed for human development. Nodules are also the easiest seafloor mineral deposit to collect.
Economically viable nodules take millions of years to form, sitting on the seafloor the whole time. A nodule is born when a resilient bit of matter, such as a shark tooth, winds up on the ocean floor. Minerals with iron, manganese and other metals slowly accumulate like a snowball. The largest are the size of a grapefruit.
Life accumulates on the nodules, too. Microbial organisms, invertebrates, corals and sponges all live on the nodules, and sea stars, crustaceans, worms and other life-forms scuttle around them.
About half of the known life in flat, vast expanses of seafloor called the abyssal plain live on these nodules, said Lisa Levin, an oceanographer at the Scripps Institution of Oceanography. But “we don’t know how widespread species are, or whether if you mine one area, there would be individuals that could recolonize another place,” she said. “That’s a big unknown.”
How do you mine the sea?
Two main approaches to nodule mining are being developed. One is basically a claw, scraping along the seabed and collecting nodules as it goes. Another is essentially an industrial vacuum for the sea.
In both, the nodules would be brought up to ships on the surface, miles above the ocean floor. Leftover water, rock and other debris would be dropped back into the ocean.
Both dredging and vacuuming would greatly disturb, if not destroy, the seafloor habitat itself. Removing the nodules also means removing what scientists think is the main habitat for organisms on the abyssal plain.
Mining activities would also introduce light and noise pollution not only to the seafloor, but also to the ocean surface where the ship would be.
Of central concern are the plumes of sediment that mining would create, both at the seafloor and at depths around 1,000 meters, which have “some of the clearest ocean waters,” said Jeffrey Drazen, an oceanographer at the University of Hawaii at Manoa. Sediment plumes, which could travel vast distances, could throw life off in unpredictable ways.
Sediment could choke fish and smother filter-feeders like shrimp and sponges. It could block what little light gets transmitted in the ocean, preventing lanternfish from finding mates and anglerfish from luring prey. And laden with discarded metals, there’s also a chance it could pollute the seafood that people eat.
“How likely is it that we would contaminate our food supply?” Dr. Drazen said. Before mining begins, “I really would like an answer to that question. And we don’t have one now.”
What do mining companies say?
Mining companies say that they are developing sustainable, environmentally friendly deep-sea mining approaches through research and engagement with the scientific community.
Their research has included basic studies of seafloor geology, biology and chemistry, documenting thousands of species and providing valuable deep-sea photos and video. Interest in seafloor mining has supported research that might have been challenging to fund otherwise, Dr. Drazen said.
Preliminary tests of recovery equipment have provided some insights into foreseeable effects of their practices like sediment plumes, although modeling can only go so far in predicting what would happen once mining reached a commercial scale.
Impossible Metals, a seafloor mining company based in California, is developing an underwater robot the size of a shipping container that uses artificial intelligence to hand pick nodules without larger organisms, an approach it claims minimizes sediment plumes and biological disturbance. The Metals Company, a Canadian deep-sea mining company, in 2022 successfully recovered roughly 3,000 tons of nodules from the seafloor, collecting data on the plume and other effects in the process.
The Metals Company in March announced that it would seek a permit for seafloor mining through NOAA, circumventing the International Seabed Authority, the United Nations-affiliated organization set up to regulate seafloor mining.
Gerard Barron, the company’s chief executive, said in an interview on Thursday that the executive order was “not a shortcut” past environmental reviews and that the company had “completed more than a decade of environmental research.”
Anna Kelly, a White House spokeswoman, said the United States would abide by two American laws that govern deep-sea exploration and commercial activities in U.S. waters and beyond. “Both of these laws require comprehensive environmental impact assessments and compliance with strong environmental protection standards,” she said.
What are the long-term risks?
Many scientists remain skeptical that enough is known about seafloor mining’s environmental effects to move forward. They can only hypothesize about the long-term consequences.
Disrupting the bottom of the food chain could have ripple effects throughout the ocean environment. An extreme example, Dr. Drazen said, would be if sediment diluted the food supply of plankton. In that case they could starve, unable to scavenge enough organic matter from a cloud of sea dust.
Tiny plankton are a fundamental food source, directly or indirectly, for almost every creature in the ocean, up to and including whales.
Part of the challenge in understanding potential effects is that the pace of life is slow on the seafloor. Deep-sea fish can live hundreds of years. Corals can live thousands.
“It’s a different time scale of life,” Dr. Levin said. “That underpins some of the unknowns about responses to disturbances.” It’s hard for humans to do 500-year-long experiments to understand if or when ecosystems like these can bounce back or adapt.
And there are no guarantees of restoring destroyed habitats or mitigating damage on the seafloor. Unlike mining on land, “we don’t have those strategies for the deep sea,” Dr. Orcutt said. “There’s not currently scientific evidence that we can restore the ecosystem after we’ve damaged it.”
Some scientists question the need for seafloor mining at all, saying that mines on land could meet growing demand for metals.
Proponents of deep-sea mining have claimed that its environmental or carbon footprint would be smaller than traditional mining for those same minerals.
“There has been no actual recovery of minerals to date,” said Amy Gartman, an ocean researcher who leads the United States Geological Survey seabed minerals team, referring to commercial-scale mining. “We’re comparing theoretical versus actual, land-based mining practices. If and when someone actually breaks ground on one of these projects, we’ll get a better idea.”
Eric Lipton contributed reporting.
Science
Contributor: RFK Jr.'s rhetoric masks the real tragedy people with autism are facing
As the leader of a nonprofit that supports thousands of children and adults with developmental disabilities across Los Angeles County, I’ve seen firsthand the strength, resilience and dignity of families raising children with autism. So when I heard the U.S. secretary of Health and Human Services claim last week that autism “destroys” children and families and is “catastrophic for our country,” I was deeply disturbed but sadly, not surprised.
Robert F. Kennedy Jr.’s overwrought remarks, like many made in public discourse about autism, reduce complex human stories to simple tragedy. They paint individuals and families as broken. They perpetuate the outdated idea that an autism diagnosis is, starkly, an ending, not a beginning. And for families already facing daily challenges — navigating school systems, medical insurance, therapies, and work, life and caregiving balances — this kind of language is another blow.
What’s worse, it distracts from real, urgent issues facing these families right now — especially proposed cuts to Medicaid that could devastate the supports they rely on.
To be clear: The prevalence of autism is rising. The Centers for Disease Control and Prevention now estimates that 1 in 31 children in the U.S. is diagnosed with autism, up from 1 in 36 just a few years ago. But that doesn’t mean autism is a catastrophe. The CDC says the change reflects better awareness, improved diagnostic tools and more families — especially in underserved communities — gaining access to the evaluations and services their children need.
Here in California, the state Department of Developmental Services serves more than 400,000 adults and children with developmental disabilities, including autism. That’s a 40% increase over the past decade, but services that are available haven’t kept pace. From early intervention help and behavioral therapy to job support and independent living programs, families often face long wait lists and limited options, particularly in working-class and low-income communities.
Now, just as more families are seeking help, some federal lawmakers are calling for Medicaid budget cuts that could threaten services for millions of Americans with disabilities. More than 15 million people with disabilities rely on Medicaid nationwide, including more than 1.9 million here in California.
These are the threats we should be talking about. Not manufactured panic over vaccines. Not unfounded theories about the cause of autism. And certainly not careless words that make families feel ashamed for seeking support.
Kennedy is right about one thing: Families matter. But if we truly care about them, we must protect — not politicize — them. I’ve met single parents working two jobs who spend their nights filling out paperwork to get their child approved for therapy. I’ve seen siblings step up to care for brothers and sisters navigating their own adolescence. I’ve seen entire families become fierce advocates, building welcoming communities where their children can thrive.
What these families need is not blame, but investment. In services. In housing. In employment pathways. In research — yes — but also in dignity, and the right to a full, self-determined life.
The individuals my organization serves are not “destroyed.” They are learning, working, creating art, volunteering, making friends and building lives of purpose. The caregivers, educators and direct service providers who support them are not defeated — they are relentless. And their stories deserve to be told not as cautionary tales, but as testaments to possibility.
So instead of invoking fear, let’s focus on the future. Let’s commit to equitable access to services. Let’s ensure California leads the nation in supporting people with autism and developmental disabilities. And let’s reject rhetoric that stigmatizes difference and isolates those who live it.
Los Angeles is a city built on diversity, innovation, and heart. Our disability community is no different. It’s time we honor their contributions — not with pity or panic, but with partnership and progress.
Veronica A. Arteaga is president and CEO of the Exceptional Children Foundation, headquartered in Culver City.
Science
What Nearly Brainless Rodents Know About Weight Loss and Hunger

Do we really have free will when it comes to eating? It’s a vexing question that is at the heart of why so many people find it so difficult to stick to a diet.
To get answers, one neuroscientist, Harvey J. Grill of the University of Pennsylvania, turned to rats and asked what would happen if he removed all of their brains except their brainstems. The brainstem controls basic functions like heart rate and breathing. But the animals could not smell, could not see, could not remember.
Would they know when they had consumed enough calories?
To find out, Dr. Grill dripped liquid food into their mouths.
“When they reached a stopping point, they allowed the food to drain out of their mouths,” he said.
Those studies, initiated decades ago, were a starting point for a body of research that has continually surprised scientists and driven home that how full animals feel has nothing to do with consciousness. The work has gained more relevance as scientists puzzle out how exactly the new drugs that cause weight loss, commonly called GLP-1s and including Ozempic, affect the brain’s eating-control systems.
The story that is emerging does not explain why some people get obese and others do not. Instead, it offers clues about what makes us start eating, and when we stop.
While most of the studies were in rodents, it defies belief to think that humans are somehow different, said Dr. Jeffrey Friedman, an obesity researcher at Rockefeller University in New York. Humans, he said, are subject to billions of years of evolution leading to elaborate neural pathways that control when to eat and when to stop eating.
As they have probed how eating is controlled, researchers learned that the brain is steadily getting signals that hint at how calorically dense a food is. There’s a certain amount of calories that the body needs, and these signals make sure the body gets them.
The process begins before a lab animal takes a single bite. Just the sight of food spurs neurons to anticipate whether a lot of calories will be packed into that food. The neurons respond more strongly to a food like peanut butter — loaded with calories — than to a low-calorie one like mouse chow.
The next control point occurs when the animal tastes the food: Neurons calculate the caloric density again from signals sent from the mouth to the brainstem.
Finally, when the food makes its way to the gut, a new set of signals to the brain lets the neurons again ascertain the caloric content.
And it is actually the calorie content that the gut assesses, as Zachary Knight, a neuroscientist at the University of California San Francisco, learned.
He saw this when he directly infused three types of food into the stomachs of mice. One infusion was of fatty food, another of carbohydrates and the third of protein. Each infusion had the same number of calories.
In each case, the message to the brain was the same: The neurons were signaling the amount of energy, in the form of calories, and not the source of the calories.
When the brain determines enough calories were consumed, neurons send a signal to stop eating.
Dr. Knight said these discoveries surprised him. He’d always thought that the signal to stop eating would be “a communication between the gut and the brain,” he said. There would be a sensation of having a full stomach and a deliberate decision to stop eating.
Using that reasoning, some dieters try to drink a big glass of water before a meal, or fill up on low-calorie foods, like celery.
But those tricks have not worked for most people because they don’t account for how the brain controls eating. In fact, Dr. Knight found that mice do not even send satiety signals to the brain when all they are getting is water.
It is true that people can decide to eat even when they are sated, or can decide not to eat when they are trying to lose weight. And, Dr. Grill said, in an intact brain — not just a brainstem — other areas of the brain also exert control.
But, Dr. Friedman said, in the end the brain’s controls typically override a person’s conscious decisions about whether they feel a need to eat. He said, by analogy, you can hold your breath — but only for so long. And you can suppress a cough — but only up to a point.
Scott Sternson, a neuroscientist with the University of California in San Diego and Howard Hughes Medical Institute, agreed.
“There is a very large proportion of appetite control that is automatic,” said Dr. Sternson, who is also a co-founder of a startup company, Penguin Bio, that is developing obesity treatments. People can decide to eat or not at a given moment. But, he added, maintaining that sort of control uses a lot of mental resources.
“Eventually, attention goes to other things and the automatic process will wind up dominating,” he said.
As they probed the brain’s eating-control systems, researchers were continually surprised.
They learned, for example, about the brain’s rapid response to just the sight of food.
Neuroscientists had found in mice a few thousand neurons in the hypothalamus, deep in the brain, that responded to hunger. But how are they regulated? They knew from previous studies that fasting turned these hunger neurons on and that the neurons were less active when an animal was well fed.
Their theory was that the neurons were responding to the body’s fat stores. When fat stores were low — as happens when an animal fasts, for example — levels of leptin, a hormone released from fat, also are low. That would turn the hunger neurons on. As an animal eats, its fat stores are replenished, leptin levels go up, and the neurons, it was assumed, would quiet down.
The whole system was thought to respond only slowly to the state of energy storage in the body.
But then three groups of researchers, independently led by Dr. Knight, Dr. Sternson and Mark Andermann of Beth Israel Deaconess Medical Center, examined the moment-to-moment activity of the hunger neurons.
They began with hungry mice. Their hunger neurons were firing rapidly, a sign the animals needed food.
The surprise happened when the investigators showed the animals food.
“Even before the first bite of food, the activity of those neurons shut off,” Dr. Knight said. “The neurons were making a prediction. The mouse looks at food. The mouse predicts how many calories it will eat.”
The more calorie-rich the food, the more neurons turn off.
“All three labs were shocked,” said Dr. Bradford B. Lowell, who worked with Dr. Andermann at Beth Israel Deaconess. “It was very unexpected.”
Dr. Lowell then asked what might happen if he deliberately turned off the hunger neurons even though the mice hadn’t had much to eat. Researchers can do this with genetic manipulations that mark neurons so they can turn them on and off with either a drug or with a blue light.
These mice would not eat for hours, even with food right in front of them.
Dr. Lowell and Dr. Sternson independently did the opposite experiment, turning the neurons on in mice that had just had a huge meal, the mouse equivalent of a Thanksgiving dinner. The animals were reclining, feeling stuffed.
But, said Dr. Andermann, who repeated the experiment, when they turned the hunger neurons on, “The mouse gets up and eats another 10 to 15 percent of its body weight.” He added, “The neurons are saying, ‘Just focus on food.’”
Researchers continue to be amazed by what they are finding — layers of controls in the brain that ensure eating is rigorously regulated. And hints of new ways to develop drugs to control eating.
One line of evidence was discovered by Amber Alhadeff, a neuroscientist at the Monell Chemical Senses Center and the University of Pennsylvania. She recently found two separate groups of neurons in the brainstem that respond to the GLP-1 obesity drugs.
One group of neurons signaled that the animals have had enough to eat. The other group caused the rodent equivalent of nausea. The current obesity drugs hit both groups of neurons, she reports, which may be a factor in the side effects many feel. She proposes that it might be possible to develop drugs that hit the satiety neurons but not the nausea ones.
Alexander Nectow, of Columbia University, has another surprise discovery. He identified a group of neurons in the brainstem that regulate how big a meal is desired, tracking each bite of food. “We don’t know how they do it,” he said.
“I’ve been studying this brainstem region for a decade and a half,” Dr. Nectow said, “but when we went and used all of our fancy tools, we found this population of neurons we had never studied.”
He’s now asking if the neurons could be targets for a class of weight loss drugs that could upstage the GLP-1s.
“That would be really amazing,” Dr. Nectow said.
-
Education1 week ago
Video: Shooting at Florida State University Leaves 2 Dead and 6 Injured
-
News1 week ago
Harvard would be smart to follow Hillsdale’s playbook. Trump should avoid Biden’s. | Opinion
-
Business1 week ago
Porto's Bakery moving forward in Downtown Disney, replacing Earl of Sandwich
-
Politics1 week ago
Supreme Court blocks new deportations of Venezuelans in Texas under 18th century Alien Enemies Act
-
Politics6 days ago
Video: Hegseth Attacks the Media Amid New Signal Controversy
-
Culture4 days ago
New Poetry Books That Lean Into Calm and Joy Amid Life’s Chaos
-
News1 week ago
The NHL Stanley Cup Playoffs begin Saturday. Here's what to watch for
-
Politics6 days ago
Pope Francis and US presidents: A look back at his legacy with the nation's leaders